Itacitinib + Everolimus in Hodgkin Lymphoma
Clinical trial NCT03697408 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03697408
- Sponsor
- University of Pennsylvania
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-11
- Primary completion
- 2024-05-20
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.